[go: up one dir, main page]

ITRM20080182A1 - Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma. - Google Patents

Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.

Info

Publication number
ITRM20080182A1
ITRM20080182A1 IT000182A ITRM20080182A ITRM20080182A1 IT RM20080182 A1 ITRM20080182 A1 IT RM20080182A1 IT 000182 A IT000182 A IT 000182A IT RM20080182 A ITRM20080182 A IT RM20080182A IT RM20080182 A1 ITRM20080182 A1 IT RM20080182A1
Authority
IT
Italy
Prior art keywords
dorzolamide
latanoprost
glaucoma
preparation based
ophthalmic preparation
Prior art date
Application number
IT000182A
Other languages
English (en)
Inventor
Danilo Aleo
Sergio Mangiafico
Maria Grazia Antonietta Saita
Original Assignee
Medivis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivis S R L filed Critical Medivis S R L
Priority to IT000182A priority Critical patent/ITRM20080182A1/it
Priority to US12/936,640 priority patent/US8680078B2/en
Priority to AU2008354558A priority patent/AU2008354558B2/en
Priority to JP2011503508A priority patent/JP2011516537A/ja
Priority to PCT/IB2008/003381 priority patent/WO2009125246A1/en
Priority to CN2012105962691A priority patent/CN103181919A/zh
Priority to EP13193754.2A priority patent/EP2710999A1/en
Priority to CN2008801296744A priority patent/CN102046149B/zh
Priority to EP08873876.0A priority patent/EP2280689B1/en
Publication of ITRM20080182A1 publication Critical patent/ITRM20080182A1/it
Priority to US14/180,254 priority patent/US20140163030A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT000182A 2008-04-07 2008-04-07 Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma. ITRM20080182A1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT000182A ITRM20080182A1 (it) 2008-04-07 2008-04-07 Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.
US12/936,640 US8680078B2 (en) 2008-04-07 2008-11-07 Stable ophthalmic formulations
AU2008354558A AU2008354558B2 (en) 2008-04-07 2008-11-07 Stable ophthalmic formulations
JP2011503508A JP2011516537A (ja) 2008-04-07 2008-11-07 安定性のある眼科用の製剤
PCT/IB2008/003381 WO2009125246A1 (en) 2008-04-07 2008-11-07 Stable ophthalmic formulations
CN2012105962691A CN103181919A (zh) 2008-04-07 2008-11-07 稳定的眼药制剂
EP13193754.2A EP2710999A1 (en) 2008-04-07 2008-11-07 Stable ophthalmic formulations
CN2008801296744A CN102046149B (zh) 2008-04-07 2008-11-07 稳定的眼药制剂
EP08873876.0A EP2280689B1 (en) 2008-04-07 2008-11-07 Stable ophthalmic formulations
US14/180,254 US20140163030A1 (en) 2008-04-07 2014-02-13 Stable ophthalmic formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000182A ITRM20080182A1 (it) 2008-04-07 2008-04-07 Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.

Publications (1)

Publication Number Publication Date
ITRM20080182A1 true ITRM20080182A1 (it) 2009-10-08

Family

ID=40297206

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000182A ITRM20080182A1 (it) 2008-04-07 2008-04-07 Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.

Country Status (7)

Country Link
US (2) US8680078B2 (it)
EP (2) EP2710999A1 (it)
JP (1) JP2011516537A (it)
CN (2) CN103181919A (it)
AU (1) AU2008354558B2 (it)
IT (1) ITRM20080182A1 (it)
WO (1) WO2009125246A1 (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20080182A1 (it) 2008-04-07 2009-10-08 Medivis S R L Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.
US10463677B2 (en) * 2008-11-07 2019-11-05 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
WO2010089355A1 (en) * 2009-02-04 2010-08-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
JP6038786B2 (ja) 2010-07-22 2016-12-07 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドＲａｍｏｔ Ａｔ Ｔｅｌ Ａｖｉｖ Ｕｎｉｖｅｒｓｉｔｙ Ｌｔｄ． トリプトファン誘導体を含有する薬学的組成物
WO2012021107A2 (en) 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
KR20130100273A (ko) * 2010-08-27 2013-09-10 와카모토 세이야꾸 가부시끼가이샤 점안용 수성 조성물
CN102961748A (zh) * 2011-08-30 2013-03-13 香港理工大学 使用缝隙连接阻断剂降低眼压的方法
EP2567689A1 (en) * 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
WO2013087808A1 (en) 2011-12-15 2013-06-20 Merz Pharma Gmbh & Co. Kgaa Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
JP6373867B2 (ja) * 2012-12-19 2018-08-15 サルコード・バイオサイエンス・インコーポレイテッド Ｌｆａ−１阻害剤製剤
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
WO2016072939A1 (en) * 2014-11-07 2016-05-12 National University Of Singapore Formulations comprising antimicrobial agents with hydrophobic moieties and uses thereof
TW201701877A (zh) * 2015-02-23 2017-01-16 參天製藥股份有限公司 含有多佐胺之防腐劑
CN104740205A (zh) * 2015-03-14 2015-07-01 焦永法 一种治疗外伤性前房积血的中药制剂
HK1248570A1 (zh) 2015-05-29 2018-10-19 西德奈克西斯公司 D2o穩定化的藥物製劑
PT3193832T (pt) * 2015-06-17 2019-10-25 Al Chi Mi A S R L Preparação viscoelástica para utilização em métodos cirúrgicos de cirurgia oftálmica.
JP6050454B1 (ja) * 2015-09-28 2016-12-21 参天製薬株式会社 水性医薬組成物
GR1009040B (el) * 2016-04-19 2017-05-19 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
CN106967515A (zh) * 2016-04-19 2017-07-21 明基材料股份有限公司 隐形眼镜保养液
US20180318319A1 (en) 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
EA202092472A1 (ru) 2018-04-18 2021-03-25 Ай.КОМ МЕДИКАЛ ГМБХ Высокомолекулярная гиалуроновая кислота для лечения и предупреждения тяжелого заболевания глазной поверхности
WO2020157570A1 (en) 2019-01-31 2020-08-06 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
MX2021009509A (es) * 2019-02-06 2021-09-08 Tearclear Corp Sistemas y metodos para la eliminacion de conservantes de las formulaciones oftalmicas que comprenden agentes complejantes.
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
WO2021260430A1 (en) * 2020-06-21 2021-12-30 i.com medical GmbH Use of high molecular weight hyaluronic acid as ocular transporting vehicle
EP4309644A1 (en) * 2022-07-22 2024-01-24 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Preservative-free ophthalmic composition comprising an antiglaucoma agent
MX2023009955A (es) * 2023-08-24 2025-03-07 Sophia Holdings S A De C V Composiciones farmaceuticas oftalmicas que contienen dorzolamida, metodos para su preparacion y uso de las mismas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494901A (en) 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
AU741525B2 (en) * 1998-03-06 2001-12-06 Board Of Regents, The University Of Texas System Composition and method for treating macular disorders
US20030018079A1 (en) 2000-11-13 2003-01-23 Richardson Helene Treatment
JP4314429B2 (ja) * 2002-08-23 2009-08-19 参天製薬株式会社 ラタノプロストを有効成分とする安定な点眼液
BRPI0418866A (pt) * 2004-05-26 2007-11-20 Arturo Jimenez Bayardo métodos para solubilizar o latanoprost e para preparar uma solução oftálmica aquosa de latanoprost e solução resultante
EP1848541A4 (en) 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR THE OPHTHALMIC ADMINISTRATION OF PHARMACEUTICAL ACTIVE SUBSTANCES
ITRM20080182A1 (it) 2008-04-07 2009-10-08 Medivis S R L Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.

Also Published As

Publication number Publication date
EP2710999A1 (en) 2014-03-26
JP2011516537A (ja) 2011-05-26
WO2009125246A1 (en) 2009-10-15
AU2008354558A1 (en) 2009-10-15
US20140163030A1 (en) 2014-06-12
EP2280689A1 (en) 2011-02-09
EP2280689B1 (en) 2014-07-23
US20110028477A1 (en) 2011-02-03
CN102046149B (zh) 2013-01-30
US8680078B2 (en) 2014-03-25
CN102046149A (zh) 2011-05-04
CN103181919A (zh) 2013-07-03
AU2008354558B2 (en) 2013-07-25

Similar Documents

Publication Publication Date Title
ITRM20080182A1 (it) Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma.
LTPA2019504I1 (lt) Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
BRPI0920137A2 (pt) implante ocular
BR112012020050A8 (pt) acessório ocular iluminado
IL212782A (en) Base for disinfecting lenses
EP2528562A4 (en) DISPLAY FOR AN EYE SURGERY CONSOLE WITH USER-SELECTABLE SECTORS
DE502008000337D1 (de) Einrichtung fuer die laseroptische Augenchirurgie
EP2424360A4 (en) TOPICAL, PERIOCULAR OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES
EP2303184A4 (en) COMBINATION TREATMENT OF GREEN STAR
EP2771042A4 (en) HYBRID SEAMABLE SUPERPOROUS HYDROGEL KERATOPROTHESIS FOR THE CORNEA
EP2268230A4 (en) ADJUSTABLE INTRAOCULAR LENS
PT2306948T (pt) Dispositivo para a cirurgia a laser oftalmológica, particularmente refrativa
BRPI0911577A2 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
CL2013002934A1 (es) Polimeros conjugados analogos de prostaglandinas; metodo de preparacion; implante y uso en el tratamiento del glaucoma.
FR2973218B1 (fr) Plaque d'osteosynthese.
BRPI0917440A2 (pt) composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho
IT1398378B1 (it) Citicolina per il trattamento del glaucoma e dell'ipertensione oculare.
ITMI20070890A1 (it) Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma
EP2481416A4 (en) EYE DROP
IT201600128780A1 (it) Bastoncino igienico per la cura della persona,in particolare per l’igiene dell’orecchio
FR2955026B1 (fr) Injecteur pour implant ophtalmologique pliable.
IT1399941B1 (it) Procedimento per la divisione di tavole di grande formato e dispositivo per l'esecuzione del procedimento
IT1393011B1 (it) Astina di occhiali a posizione e lunghezza regolabili, particolarmente per bambini.
IT1404355B1 (it) " occhiali per nuoto " .
TH0901004708A (th) สารประกอบที่เกิดพันธะกับไนโตรเจนสำหรับรักษาโรคและความผิดปกติเกี่ยวกับตา